Myeloid Cell Origins, Differentiation, and Clinical Implications

Area of Science:

• Hematology
• Stem Cell Biology
• Immunology

Background:

• Hematopoietic stem cells (HSCs) are multipotent cells in bone marrow forming all blood and immune cells.
• Hematopoiesis, the process of blood cell formation, is divided into myeloid and lymphoid lineages.
• HSC development and function have been refined since their purification in 1988.

Purpose of the Study:

• To review the stages and regulation of hematopoiesis, focusing on myeloid development.
• To highlight the implications of understanding myeloid development for disease and therapy.
• To discuss the role of the CD47/SIRPα axis in HSC regulation and cancer.

Main Methods:

• Review of existing literature on hematopoiesis and myeloid cell development.
• Analysis of the stages of hematopoiesis in mice and humans.
• Examination of the CD47/SIRPα immune checkpoint's role in myeloid cell interactions.

Main Results:

• Hematopoiesis occurs in distinct stages, originating in the yolk sac and migrating to fetal organs.
• Aging influences HSCs, biasing development toward myeloid lineages.
• The CD47/SIRPα axis regulates macrophage-mediated removal of HSCs and is implicated in malignancies.

Conclusions:

• Insights into myeloid development are crucial for understanding and treating hematologic disorders.
• Targeting the CD47/SIRPα axis presents a novel therapeutic strategy for cancer.
• Advances in hematopoiesis research have broad implications for regenerative medicine and transplantation.